Melissa Palmer

Melissa Palmer

Technik-/Wissenschafts-/F&E-Leiter bei CYTODYN INC.
Health Technology
Consumer Services
Health Services

Profil

Melissa Palmer is currently the Chief Medical Officer at CytoDyn, Inc. She previously worked as the Hepatology Director at New York University.
In 2019, she was the Head-Liver Disease Clinical Development at Takeda Pharmaceutical Co., Ltd. From 2020 to 2022, she served as the Chief Medical Officer at Ascletis Pharma, Inc. and Gannex Pharma Co Ltd. Dr. Palmer is also a Professor at NYU Langone Health.
She completed her undergraduate degree at The Trustees of Columbia University in The City of New York and obtained her doctorate from Icahn School of Medicine at Mount Sinai.

Aktive Positionen von Melissa Palmer

UnternehmenPositionBeginn
CYTODYN INC. Technik-/Wissenschafts-/F&E-Leiter 24.05.2023

Ehemalige bekannte Positionen von Melissa Palmer

UnternehmenPositionEnde
Technik-/Wissenschafts-/F&E-Leiter 01.03.2022
ASCLETIS PHARMA INC. Technik-/Wissenschafts-/F&E-Leiter 01.03.2022
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01.08.2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Melissa Palmer im Detail an

Ausbildung von Melissa Palmer

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

35

Beziehungen ersten Grades

8

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen8

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Melissa Palmer